Instent, established in 1991, developed a wide range of medical stents which are used to keep patency of body ducts and tubes such as blood vessels, common bile ducts and the male urethra. The company had a strong intellectual property protection on its stent insertion technique. Instent went public in 1995 in the US (NASDAQ: ININ) and was acquired in 1996 by Medtronic Inc. (NYSE:MDT).
    Symbol: MDT (NYSE)  
    Status: Acquired  
    Fund I  
    Founded 1991  

Neomedia - Keepin' it simple!